136 related articles for article (PubMed ID: 15795103)
1. Physiological, pharmacological and clinical features of the multidrug resistance protein 2.
Fardel O; Jigorel E; Le Vee M; Payen L
Biomed Pharmacother; 2005 Apr; 59(3):104-14. PubMed ID: 15795103
[TBL] [Abstract][Full Text] [Related]
2. The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds.
Payen L; Sparfel L; Courtois A; Vernhet L; Guillouzo A; Fardel O
Cell Biol Toxicol; 2002; 18(4):221-33. PubMed ID: 12206135
[TBL] [Abstract][Full Text] [Related]
3. The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance.
Hoffmann U; Kroemer HK
Drug Metab Rev; 2004 Oct; 36(3-4):669-701. PubMed ID: 15554242
[TBL] [Abstract][Full Text] [Related]
4. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
[TBL] [Abstract][Full Text] [Related]
5. Modulation of expression and activity of intestinal multidrug resistance-associated protein 2 by xenobiotics.
Tocchetti GN; Rigalli JP; Arana MR; Villanueva SSM; Mottino AD
Toxicol Appl Pharmacol; 2016 Jul; 303():45-57. PubMed ID: 27155371
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance-associated proteins and implications in drug development.
Liu YH; Di YM; Zhou ZW; Mo SL; Zhou SF
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):115-20. PubMed ID: 19566819
[TBL] [Abstract][Full Text] [Related]
7. Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice.
Vlaming ML; Mohrmann K; Wagenaar E; de Waart DR; Elferink RP; Lagas JS; van Tellingen O; Vainchtein LD; Rosing H; Beijnen JH; Schellens JH; Schinkel AH
J Pharmacol Exp Ther; 2006 Jul; 318(1):319-27. PubMed ID: 16611851
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition.
Jedlitschky G; Hoffmann U; Kroemer HK
Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):351-66. PubMed ID: 16863439
[TBL] [Abstract][Full Text] [Related]
9. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition.
Gerk PM; Vore M
J Pharmacol Exp Ther; 2002 Aug; 302(2):407-15. PubMed ID: 12130697
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2).
Chu XY; Strauss JR; Mariano MA; Li J; Newton DJ; Cai X; Wang RW; Yabut J; Hartley DP; Evans DC; Evers R
J Pharmacol Exp Ther; 2006 May; 317(2):579-89. PubMed ID: 16421286
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships for interaction with multidrug resistance protein 2 (ABCC2/MRP2): the role of torsion angle for a series of biphenyl-substituted heterocycles.
Lai Y; Xing L; Poda GI; Hu Y
Drug Metab Dispos; 2007 Jun; 35(6):937-45. PubMed ID: 17371800
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1beta represses MRP2 gene expression through inactivation of interferon regulatory factor 3 in HepG2 cells.
Hisaeda K; Inokuchi A; Nakamura T; Iwamoto Y; Kohno K; Kuwano M; Uchiumi T
Hepatology; 2004 Jun; 39(6):1574-82. PubMed ID: 15185298
[TBL] [Abstract][Full Text] [Related]
14. Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites.
Slot AJ; Wise DD; Deeley RG; Monks TJ; Cole SP
Drug Metab Dispos; 2008 Mar; 36(3):552-60. PubMed ID: 18079363
[TBL] [Abstract][Full Text] [Related]
15. Modulation of multidrug resistance-associated protein 2 (Mrp2) and Mrp3 expression and function with small interfering RNA in sandwich-cultured rat hepatocytes.
Tian X; Zamek-Gliszczynski MJ; Zhang P; Brouwer KL
Mol Pharmacol; 2004 Oct; 66(4):1004-10. PubMed ID: 15385645
[TBL] [Abstract][Full Text] [Related]
16. Uptake and efflux transporters for conjugates in human hepatocytes.
Keppler D
Methods Enzymol; 2005; 400():531-42. PubMed ID: 16399368
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of a novel multidrug resistance protein 2 humanized mouse line.
Scheer N; Balimane P; Hayward MD; Buechel S; Kauselmann G; Wolf CR
Drug Metab Dispos; 2012 Nov; 40(11):2212-8. PubMed ID: 22917771
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds.
Wortelboer HM; Usta M; van Zanden JJ; van Bladeren PJ; Rietjens IM; Cnubben NH
Biochem Pharmacol; 2005 Jun; 69(12):1879-90. PubMed ID: 15885658
[TBL] [Abstract][Full Text] [Related]
19. Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2).
Zimmermann C; van de Wetering K; van de Steeg E; Wagenaar E; Vens C; Schinkel AH
Drug Metab Dispos; 2008 Apr; 36(4):631-40. PubMed ID: 18180270
[TBL] [Abstract][Full Text] [Related]
20. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid.
Huisman MT; Chhatta AA; van Tellingen O; Beijnen JH; Schinkel AH
Int J Cancer; 2005 Sep; 116(5):824-9. PubMed ID: 15849751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
